Table 3.

Major bleeding rate by diagnosis after percutaneous native renal biopsy

Diagnosis on biopsy	n	Major bleeding	Transfusion	Embolization
Glomerulonephritis including HSP	1143	13 (1.1%)	12 (1.0%)	2 (0.2%)
Vasculitis	336	17 (5.1%)	14 (4.2%)	2 (0.6%)
Interstitial disease including CPN	199	4 (2.0%)	4 (2.0%)	0 (0.0%)
Chronic ischaemia	145	2 (1.4%)	0 (0.0%)	1 (0.7%)
Diabetic nephropathy	139	4 (2.9%)	4 (2.9%)	0 (0.0%)
Amyloid/myeloma	140	1 (0.7%)	1 (0.7%)	0 (0.0%)
Lupus nephritis	111	2 (1.8%)	2 (2.6%)	1 (0.9%)
Acute tubular injury	96	0 (0.0%)	0 (0.0%)	0 (0.0%)
Others	88	5 (5.7%)	4 (4.5%)	3 (3.4%)
Non-diagnostic	164	5 (3.0%)	5 (3.0%)	0 (0.0%)

CPN, Chlamydia pneumoniae; HSP, Henoch–Schönlein Purpura.